Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, par value CHF 0.05 per share
-
Shares outstanding
-
66,413,214
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
17,872,624
-
Shares change
-
-367
-
Total reported value, excl. options
-
$65,159,858
-
Value change
-
-$395,956
-
Put/Call ratio
-
5.1%
-
Number of buys
-
12
-
Number of sells
-
11
-
Price
-
$3.65
Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) as of Q3 2024
As of 30 Sep 2024 SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) had 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,872,624 shares of stock of the company.
Largest 10 holders included GENERATION INVESTMENT MANAGEMENT LLP, BANQUE PICTET & CIE SA, AKRE CAPITAL MANAGEMENT LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, PRINCIPAL FINANCIAL GROUP INC, Alta Wealth Advisors LLC, MILLENNIUM MANAGEMENT LLC, Bank Pictet & Cie (Europe) AG, EDMOND DE ROTHSCHILD HOLDING S.A., and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 30 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.